Atlas Trials

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Clinical trial NCT07070479 · RECRUITING

Trial details

NCT number
NCT07070479
Sponsor
Ming-Yuan Chen
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Nasopharyngeal Carcinoma
Start date
2025-06-24
Primary completion
2027-01-30
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.